AXVNX
Price
$18.58
Change
-$0.73 (-3.78%)
Updated
Dec 18 closing price
VSIAX
Price
$85.23
Change
-$3.35 (-3.78%)
Updated
Dec 18 closing price
Ad is loading...

AXVNX vs VSIAX

Header iconAXVNX vs VSIAX Comparison
Open Charts AXVNX vs VSIAXBanner chart's image
Acclivity Small Cap Value N
Price$18.58
Change-$0.73 (-3.78%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Value Index Admiral
Price$85.23
Change-$3.35 (-3.78%)
VolumeN/A
CapitalizationN/A
AXVNX vs VSIAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AXVNX vs. VSIAX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AXVNX is a Hold and VSIAX is a Hold.

FUNDAMENTALS
Fundamentals
VSIAX has more cash in the bank: 63B vs. AXVNX (39.4M). VSIAX pays higher dividends than AXVNX: VSIAX (2.01) vs AXVNX (0.52). AXVNX was incepted earlier than VSIAX: AXVNX (6 years) vs VSIAX (13 years). AXVNX is a more actively managed with annual turnover of: 56.00 vs. VSIAX (16.00). VSIAX has a lower initial minimum investment than AXVNX: VSIAX (3000) vs AXVNX (5000). VSIAX annual gain was more profitable for investors over the last year : 16.23 vs. AXVNX (5.60). AXVNX return over 5 years is better than : 68.13 vs. VSIAX (52.83).
AXVNXVSIAXAXVNX / VSIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence6 years13 years-
Gain YTD3.19915.03121%
Front LoadN/AN/A-
Min. Initial Investment50003000167%
Min. Initial Investment IRAN/AN/A-
Net Assets39.4M63B0%
Annual Yield % from dividends0.522.0126%
Returns for 1 year5.6016.2335%
Returns for 3 years21.8420.67106%
Returns for 5 years68.1352.83129%
Returns for 10 yearsN/A105.65-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALTO1.470.04
+2.80%
Alto Ingredients
ADXN7.80-0.05
-0.64%
Addex Therapeutics Ltd
DCOM33.96-0.84
-2.41%
Dime Community Bancshares
CAVA123.37-3.42
-2.70%
CAVA Group
EWTX30.17-2.52
-7.71%
Edgewise Therapeutics